Conclusions: The study developed a UPR-related gene classifier and risk signature for predicting survival in stomach cancer, identifying IGFBP1 as a key factor promoting the disease’s malignancy and a potential therapeutic target. Here, IGFBP1 is linked to gastric cancer.